Atea Pharmaceuticals GAAP EPS of -$0.44 beats by $0.01

2 hours ago 2
  • Atea Pharmaceuticals press release (NASDAQ:AVIR): Q2 GAAP EPS of -$0.44 beats by $0.01.
  • Cash, Cash Equivalents and Marketable Securities: $379.7 million at June 30, 2025 compared to $454.7 million at December 31, 2024.

Recommended For You

More Trending News

Read Entire Article